Rodman David Malcom
Insider CIK 1672659 · NVLS Exec Vice President and CMO · MLYS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-08-10 | 2026-08-12 | 2,170 | — | $0 | 13,024 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-08-10 | 2026-08-12 | 2,170 | $27.09 | $58.8K | 51,384 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-08-10 | 2026-08-12 | 2,170 | $16.00 | $34.7K | 53,554 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-08-10 | 2026-08-12 | 2,170 | — | $0 | 13,024 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-08-10 | 2026-08-12 | 2,170 | $27.09 | $58.8K | 51,384 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-08-10 | 2026-08-12 | 2,170 | $16.00 | $34.7K | 53,554 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-07-17 | 2026-07-20 | 416 | — | $0 | 3,334 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-07-17 | 2026-07-20 | 416 | $26.53 | $11.0K | 51,384 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-07-17 | 2026-07-20 | 416 | $15.44 | $6.4K | 51,800 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-07-15 | 2026-07-15 | 6,349 | $26.61 | $168.9K | 51,384 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-07-13 | 2026-07-15 | 4,167 | — | $0 | 79,167 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-07-13 | 2026-07-15 | 3,542 | — | $0 | 109,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-07-13 | 2026-07-15 | 6,349 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-07-13 | 2026-07-15 | 6,349 | $1.08 | $6.9K | 71,791 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-07-13 | 2026-07-15 | 3,542 | $10.20 | $36.1K | 61,275 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-07-13 | 2026-07-15 | 14,058 | $27.58 | $387.7K | 57,733 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-07-13 | 2026-07-15 | 4,167 | $14.25 | $59.4K | 65,442 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-07-09 | 2026-07-10 | 2,171 | — | $0 | 15,194 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-07-09 | 2026-07-10 | 2,171 | $30.30 | $65.8K | 57,733 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-07-09 | 2026-07-10 | 2,171 | $16.00 | $34.7K | 59,904 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-17 | 2026-06-17 | 417 | — | $0 | 3,750 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-17 | 2026-06-17 | 4,167 | — | $0 | 83,334 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-17 | 2026-06-17 | 4,167 | $14.25 | $59.4K | 61,262 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-17 | 2026-06-17 | 4,584 | $25.00 | $114.6K | 57,095 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-17 | 2026-06-17 | 417 | $15.44 | $6.4K | 61,679 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-15 | 2026-06-17 | 3,542 | — | $0 | 113,334 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-15 | 2026-06-17 | 9,890 | $23.81 | $235.5K | 57,095 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-15 | 2026-06-17 | 3,542 | $10.20 | $36.1K | 66,985 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-12 | 2026-06-12 | 6,349 | — | $0 | 6,349 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-12 | 2026-06-12 | 6,349 | $1.08 | $6.9K | 69,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-12 | 2026-06-12 | 6,349 | $23.93 | $151.9K | 63,443 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-06-10 | 2026-06-12 | 2,170 | — | $0 | 17,365 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-06-10 | 2026-06-12 | 2,170 | $16.00 | $34.7K | 65,613 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-10 | 2026-06-12 | 2,170 | $25.00 | $54.3K | 63,443 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-05-18 | 2026-05-19 | 417 | — | $0 | 4,167 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-05-18 | 2026-05-19 | 417 | $27.55 | $11.5K | 63,443 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-05-18 | 2026-05-19 | 417 | $15.44 | $6.4K | 63,860 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-05-13 | 2026-05-13 | 3,541 | — | $0 | 116,876 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-05-13 | 2026-05-13 | 4,166 | — | $0 | 87,501 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-05-13 | 2026-05-13 | 14,056 | $28.58 | $401.7K | 63,443 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-05-13 | 2026-05-13 | 3,541 | $10.20 | $36.1K | 73,333 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-05-13 | 2026-05-13 | 4,166 | $14.25 | $59.4K | 77,499 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-05-12 | 2026-05-13 | 6,348 | — | $0 | 12,698 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-05-12 | 2026-05-13 | 6,348 | $29.36 | $186.4K | 69,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-05-12 | 2026-05-13 | 6,348 | $1.08 | $6.9K | 76,140 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-05-11 | 2026-05-13 | 2,171 | — | $0 | 19,535 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-05-11 | 2026-05-13 | 2,171 | $16.00 | $34.7K | 71,963 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-05-11 | 2026-05-13 | 2,171 | $29.71 | $64.5K | 69,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-04-17 | 2026-04-21 | 416 | — | $0 | 4,584 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-04-17 | 2026-04-21 | 416 | $15.44 | $6.4K | 70,208 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-04-17 | 2026-04-21 | 416 | $31.33 | $13.0K | 69,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-04-15 | 2026-04-15 | 6,348 | $27.66 | $175.6K | 69,792 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-04-13 | 2026-04-15 | 4,167 | — | $0 | 91,667 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-04-13 | 2026-04-15 | 6,349 | — | $0 | 19,046 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-04-13 | 2026-04-15 | 3,542 | — | $0 | 120,417 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-04-13 | 2026-04-15 | 4,167 | $14.25 | $59.4K | 90,198 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-04-13 | 2026-04-15 | 14,058 | $26.54 | $373.1K | 76,140 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-04-13 | 2026-04-15 | 6,349 | $1.08 | $6.9K | 82,489 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-04-13 | 2026-04-15 | 3,542 | $10.20 | $36.1K | 86,031 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-04-09 | 2026-04-13 | 2,170 | — | $0 | 21,706 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-04-09 | 2026-04-13 | 2,170 | $27.38 | $59.4K | 76,140 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-04-09 | 2026-04-13 | 2,170 | $16.00 | $34.7K | 78,310 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-17 | 2026-03-17 | 417 | — | $0 | 5,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-17 | 2026-03-17 | 417 | $15.44 | $6.4K | 76,557 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-17 | 2026-03-17 | 417 | $25.65 | $10.7K | 76,140 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-13 | 2026-03-16 | 4,167 | — | $0 | 95,834 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-13 | 2026-03-16 | 3,542 | — | $0 | 123,959 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-13 | 2026-03-16 | 3,542 | $10.20 | $36.1K | 86,031 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-13 | 2026-03-16 | 3,079 | $27.37 | $84.3K | 76,393 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-13 | 2026-03-16 | 10,726 | $25.91 | $277.9K | 79,472 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-13 | 2026-03-16 | 4,167 | $14.25 | $59.4K | 90,198 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-13 | 2026-03-16 | 253 | $27.82 | $7.0K | 76,140 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-12 | 2026-03-16 | 6,348 | — | $0 | 25,395 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-12 | 2026-03-16 | 6,348 | $1.08 | $6.9K | 88,837 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-12 | 2026-03-16 | 6,348 | $27.37 | $173.7K | 82,489 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-03-09 | 2026-03-10 | 2,171 | — | $0 | 23,876 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-09 | 2026-03-10 | 2,171 | $26.84 | $58.3K | 82,489 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-03-09 | 2026-03-10 | 2,171 | $16.00 | $34.7K | 84,660 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 51,300 | — | $0 | 51,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 38,400 | — | $0 | 82,489 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-02-17 | 2026-02-17 | 417 | — | $0 | 5,417 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-02-17 | 2026-02-17 | 417 | $15.44 | $6.4K | 44,506 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-17 | 2026-02-17 | 417 | $27.59 | $11.5K | 44,089 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-02-13 | 2026-02-13 | 4,166 | — | $0 | 100,001 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-02-13 | 2026-02-13 | 3,541 | — | $0 | 127,501 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-02-13 | 2026-02-13 | 3,541 | $10.20 | $36.1K | 53,978 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-13 | 2026-02-13 | 3,541 | $27.33 | $96.8K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-02-13 | 2026-02-13 | 4,166 | $14.25 | $59.4K | 54,603 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-13 | 2026-02-13 | 6,348 | $27.58 | $175.1K | 44,089 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-13 | 2026-02-13 | 4,166 | $27.33 | $113.9K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-02-12 | 2026-02-13 | 6,349 | — | $0 | 31,743 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-02-12 | 2026-02-13 | 6,349 | $1.08 | $6.9K | 56,786 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-12 | 2026-02-13 | 5,828 | $28.94 | $168.7K | 50,958 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-12 | 2026-02-13 | 521 | $29.64 | $15.4K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-02-09 | 2026-02-11 | 2,171 | — | $0 | 26,047 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-02-09 | 2026-02-11 | 2,171 | $16.00 | $34.7K | 52,608 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-02-09 | 2026-02-11 | 2,171 | $30.21 | $65.6K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-20 | 2026-01-20 | 416 | — | $0 | 5,834 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-20 | 2026-01-20 | 416 | $15.44 | $6.4K | 50,853 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-20 | 2026-01-20 | 416 | $32.10 | $13.4K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-14 | 2026-01-15 | 11,367 | $32.61 | $370.7K | 50,437 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-13 | 2026-01-15 | 3,542 | — | $0 | 131,042 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-13 | 2026-01-15 | 4,167 | — | $0 | 104,167 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-13 | 2026-01-15 | 3,542 | $10.20 | $36.1K | 65,346 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-13 | 2026-01-15 | 4,167 | $14.25 | $59.4K | 69,513 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-13 | 2026-01-15 | 7,709 | $32.75 | $252.5K | 61,804 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-12 | 2026-01-13 | 6,348 | — | $0 | 38,092 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-12 | 2026-01-13 | 6,348 | $32.32 | $205.2K | 61,804 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-12 | 2026-01-13 | 6,348 | $1.08 | $6.9K | 68,152 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-09 | 2026-01-13 | 2,170 | — | $0 | 28,218 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-09 | 2026-01-13 | 2,170 | $33.27 | $72.2K | 61,804 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-09 | 2026-01-13 | 2,170 | $16.00 | $34.7K | 63,974 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-05 | 2026-01-06 | 53,630 | — | $0 | 30,388 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-05 | 2026-01-06 | 26,069 | — | $0 | 134,584 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-05 | 2026-01-06 | 10,121 | — | $0 | 6,250 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-05 | 2026-01-06 | 28,038 | — | $0 | 44,440 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-05 | 2026-01-06 | 67,473 | — | $0 | 108,334 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-05 | 2026-01-06 | 28,038 | $1.08 | $30.3K | 97,226 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-05 | 2026-01-06 | 139,245 | $34.83 | $4.85M | 115,274 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-05 | 2026-01-06 | 67,473 | $14.25 | $961.5K | 254,519 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-05 | 2026-01-06 | 53,630 | $16.00 | $858.1K | 187,046 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-05 | 2026-01-06 | 26,069 | $10.20 | $265.9K | 133,416 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-05 | 2026-01-06 | 10,121 | $15.44 | $156.3K | 107,347 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-05 | 2026-01-06 | 53,470 | $35.53 | $1.90M | 61,804 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-02 | 2026-01-06 | 24,193 | — | $0 | 175,807 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-02 | 2026-01-06 | 20,168 | — | $0 | 84,018 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-02 | 2026-01-06 | 9,347 | — | $0 | 160,653 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-02 | 2026-01-06 | 3,629 | — | $0 | 16,371 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2026-01-02 | 2026-01-06 | 10,053 | — | $0 | 72,478 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-02 | 2026-01-06 | 70,037 | $35.87 | $2.51M | 69,188 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-02 | 2026-01-06 | 24,193 | $14.25 | $344.8K | 139,225 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-02 | 2026-01-06 | 20,168 | $16.00 | $322.7K | 115,032 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-02 | 2026-01-06 | 9,347 | $10.20 | $95.3K | 94,864 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-02 | 2026-01-06 | 3,629 | $15.44 | $56.0K | 85,517 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2026-01-02 | 2026-01-06 | 10,053 | $1.08 | $10.9K | 81,888 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-10-15 | 2025-10-15 | 10,369 | $43.01 | $446.0K | 71,155 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-09-15 | 2025-09-16 | 2,065 | $36.47 | $75.3K | 81,524 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-09-15 | 2025-09-16 | 9,302 | $35.90 | $333.9K | 83,589 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-08-13 | 2025-08-14 | 11,365 | $12.93 | $146.9K | 92,891 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-08-12 | 2025-08-14 | 6,349 | — | $0 | 82,531 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-08-12 | 2025-08-14 | 6,349 | $1.08 | $6.9K | 104,256 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-07-14 | 2025-07-15 | 6,349 | — | $0 | 88,880 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-07-14 | 2025-07-15 | 6,349 | $1.08 | $6.9K | 109,273 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-14 | 2025-07-15 | 11,366 | $14.59 | $165.8K | 97,907 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-06-13 | 2025-06-16 | 11,366 | $14.60 | $165.9K | 101,651 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-06-12 | 2025-06-16 | 6,348 | — | $0 | 95,229 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-06-12 | 2025-06-16 | 6,348 | $1.08 | $6.9K | 113,017 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-05-14 | 2025-05-15 | 11,366 | $15.29 | $173.8K | 106,669 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-05-12 | 2025-05-13 | 6,349 | — | $0 | 101,577 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-05-12 | 2025-05-13 | 6,349 | $1.08 | $6.9K | 118,035 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-04-14 | 2025-04-15 | 6,348 | — | $0 | 107,926 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-14 | 2025-04-15 | 8,400 | $14.83 | $124.6K | 111,686 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-14 | 2025-04-15 | 2,966 | $13.69 | $40.6K | 120,086 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-04-14 | 2025-04-15 | 6,348 | $1.08 | $6.9K | 123,052 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,606 | — | $0 | 114,274 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-01 | 2025-04-03 | 22,406 | $16.77 | $375.7K | 116,704 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-01 | 2025-04-03 | 2,791 | $16.02 | $44.7K | 139,110 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-01 | 2025-04-03 | 30,574 | $15.00 | $458.6K | 141,901 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-04-01 | 2025-04-03 | 1,606 | $1.08 | $1.7K | 172,475 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-03-12 | 2025-03-13 | 6,349 | — | $0 | 115,880 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-03-12 | 2025-03-13 | 6,349 | $1.08 | $6.9K | 170,869 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 170,000 | — | $0 | 170,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-02-12 | 2025-02-13 | 6,348 | — | $0 | 122,229 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-02-12 | 2025-02-13 | 6,348 | $1.08 | $6.9K | 164,520 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-01-13 | 2025-01-15 | 5,018 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-01-13 | 2025-01-15 | 6,349 | — | $0 | 128,577 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-01-13 | 2025-01-15 | 6,349 | $1.08 | $6.9K | 158,172 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-01-13 | 2025-01-15 | 5,018 | $0.54 | $2.7K | 151,823 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-12-11 | 2024-12-13 | 5,017 | — | $0 | 5,018 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-12-11 | 2024-12-13 | 5,017 | $0.54 | $2.7K | 146,008 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-11-11 | 2024-11-12 | 5,017 | — | $0 | 10,035 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-11-11 | 2024-11-12 | 5,026 | — | $0 | 134,926 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-11-11 | 2024-11-12 | 5,026 | $1.08 | $5.4K | 146,017 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-11-11 | 2024-11-12 | 5,026 | $15.00 | $75.4K | 140,991 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-11-11 | 2024-11-12 | 5,017 | $0.54 | $2.7K | 140,991 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-11-06 | 2024-11-08 | 25,482 | — | $0 | 139,952 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-11-06 | 2024-11-08 | 25,482 | $15.03 | $383.0K | 135,974 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-11-06 | 2024-11-08 | 25,482 | $1.08 | $27.5K | 161,456 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-10-14 | 2024-10-15 | 5,352 | — | $0 | 165,434 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-10-14 | 2024-10-15 | 5,352 | $1.08 | $5.8K | 135,974 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-10-11 | 2024-10-15 | 5,017 | — | $0 | 15,052 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-10-11 | 2024-10-15 | 5,017 | $0.54 | $2.7K | 130,622 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-09-12 | 2024-09-12 | 6,349 | — | $0 | 170,786 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-09-12 | 2024-09-12 | 6,349 | $1.08 | $6.9K | 125,605 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-09-11 | 2024-09-12 | 5,018 | — | $0 | 20,069 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-09-11 | 2024-09-12 | 5,018 | $0.54 | $2.7K | 119,256 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-08-12 | 2024-08-13 | 6,348 | — | $0 | 177,135 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-08-12 | 2024-08-13 | 5,017 | — | $0 | 25,087 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-08-12 | 2024-08-13 | 6,348 | $1.08 | $6.9K | 114,238 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-08-12 | 2024-08-13 | 5,017 | $0.54 | $2.7K | 107,890 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-07-16 | 2024-07-18 | 525 | — | $0 | 183,483 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-07-16 | 2024-07-18 | 525 | $15.00 | $7.9K | 102,873 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-07-16 | 2024-07-18 | 525 | $1.08 | $567 | 103,398 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-07-12 | 2024-07-12 | 6,349 | — | $0 | 184,008 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-07-12 | 2024-07-12 | 6,349 | $1.08 | $6.9K | 102,873 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-07-11 | 2024-07-12 | 5,017 | — | $0 | 30,104 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-07-11 | 2024-07-12 | 5,017 | $0.54 | $2.7K | 96,524 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-06-12 | 2024-06-13 | 6,349 | — | $0 | 190,357 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-06-12 | 2024-06-13 | 6,349 | $1.08 | $6.9K | 89,729 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-06-11 | 2024-06-13 | 5,017 | — | $0 | 35,121 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-06-11 | 2024-06-13 | 5,017 | $0.54 | $2.7K | 83,380 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-05-13 | 2024-05-15 | 6,348 | — | $0 | 196,706 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-05-13 | 2024-05-15 | 5,018 | — | $0 | 40,138 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-05-13 | 2024-05-15 | 6,348 | $1.08 | $6.9K | 78,363 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-05-13 | 2024-05-15 | 5,018 | $0.54 | $2.7K | 72,015 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-05-09 | 2024-05-10 | 100 | — | $0 | 203,054 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-05-09 | 2024-05-10 | 100 | $15.00 | $1.5K | 66,997 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-05-09 | 2024-05-10 | 100 | $1.08 | $108 | 67,097 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-04-12 | 2024-04-15 | 6,349 | — | $0 | 203,154 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-04-12 | 2024-04-15 | 6,349 | $1.08 | $6.9K | 66,997 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-04-11 | 2024-04-15 | 5,017 | — | $0 | 45,156 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-04-11 | 2024-04-15 | 5,017 | $0.54 | $2.7K | 60,648 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-03-12 | 2024-03-13 | 6,348 | — | $0 | 209,503 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-03-12 | 2024-03-13 | 6,348 | $1.08 | $6.9K | 55,631 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-03-11 | 2024-03-13 | 5,017 | — | $0 | 50,173 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-03-11 | 2024-03-13 | 5,017 | $0.54 | $2.7K | 49,283 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-02-13 | 2024-02-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-02-12 | 2024-02-13 | 6,349 | — | $0 | 215,851 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-02-12 | 2024-02-13 | 5,017 | — | $0 | 55,190 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-02-12 | 2024-02-13 | 5,017 | $0.54 | $2.7K | 37,917 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-02-12 | 2024-02-13 | 6,349 | $1.08 | $6.9K | 44,266 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-01-12 | 2024-01-12 | 6,348 | — | $0 | 222,200 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-01-12 | 2024-01-12 | 6,348 | $1.08 | $6.9K | 32,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2024-01-11 | 2024-01-12 | 5,017 | — | $0 | 60,207 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2024-01-11 | 2024-01-12 | 5,017 | $0.54 | $2.7K | 26,552 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-12-11 | 2023-12-12 | 5,018 | — | $0 | 65,224 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-12-11 | 2023-12-12 | 5,018 | $0.54 | $2.7K | 20,069 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-11-13 | 2023-11-14 | 5,017 | — | $0 | 70,242 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-11-13 | 2023-11-14 | 5,017 | $0.54 | $2.7K | 15,051 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-11-03 | 2023-11-07 | 10,034 | — | $0 | 75,259 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-11-03 | 2023-11-07 | 10,034 | $0.54 | $5.4K | 10,034 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-08-11 | 2023-08-11 | 76,182 | — | $0 | 228,548 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-08-11 | 2023-08-11 | 80,909 | — | $0 | 85,293 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2023-08-11 | 2023-08-11 | 76,182 | $12.81 | $975.9K | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-08-11 | 2023-08-11 | 76,182 | $1.08 | $82.3K | 76,182 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2023-08-11 | 2023-08-11 | 80,909 | $12.81 | $1.04M | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-08-11 | 2023-08-11 | 80,909 | $0.54 | $43.7K | 80,909 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2023-08-10 | 2023-08-11 | 74,625 | — | $0 | 166,202 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2023-08-10 | 2023-08-11 | 74,625 | $13.16 | $982.1K | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2023-08-10 | 2023-08-11 | 74,625 | $0.54 | $40.3K | 74,625 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-03-17 | 2023-03-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 104,186 | — | $0 | 104,186 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | S Sale | 2017-01-04 | 2017-01-05 | 6,687 | $2.27 | $15.2K | 11,368 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 18,056 | — | $0 | 162,501 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 18,055 | — | $0 | 18,055 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | S Sale | 2016-10-04 | 2016-10-05 | 5,820 | $7.96 | $46.3K | 12,236 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise deriv | 2016-10-03 | 2016-10-05 | 18,056 | — | $0 | 180,556 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise | 2016-10-03 | 2016-10-05 | 18,056 | — | $0 | 18,056 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2016-09-12 | 2016-09-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | S Sale | 2016-07-05 | 2016-07-06 | 5,950 | $4.66 | $27.7K | 12,105 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise deriv | 2016-07-01 | 2016-07-06 | 18,055 | — | $0 | 198,612 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | M Exercise | 2016-07-01 | 2016-07-06 | 18,055 | — | $0 | 18,055 | SEC↗ |